SMC-0002 prodrug (sustained release/oral/lipophilic, oncomycosis) (SEPS)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameSMC-0002 prodrug (sustained release/oral/lipophilic, oncomycosis) (SEPS)
Drug Alias NameSMC-0002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOnychomycosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSEPS Pharma NV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSEPS Pharma NV
Active IndicationsN/A
Inactive IndicationsOnychomycosis

Other Information

ATC CodeN/A
Related LinksN/A